October 27, 2017
Article
The CDC’s ACIP recommends newly FDA-approved Shingrix as the preferred vaccine for the prevention of shingles in individuals 50 years of age or older.
Fourth COVID-19 Vaccine Dose Boosts Immunity Above Third Shot
Estrogen Treatment Reduces Risk of COVID-19 Mortality
FDA Approves Pfizer-BioNTech Booster Shot for Children 5 and Older
An Issue About COVID-19